Pfizer’s Hospital Business Unit medicines reach patients at virtually every stage of life. The depth and breadth of our portfolio of trusted medicines and capabilities, and our presence in 160 countries, enables us to deliver value to patients throughout the world.
We are proud to provide access to our quality medicines to healthcare systems and patients in both developing and emerging markets. Pfizer’s Hospital Business Unit medicines currently offers one of the industry’s largest and most diverse portfolios of anti-infectives and we’re a leader in sterile injectables and the emerging markets.
Strategic Areas of Interest
Pfizer’s Hospital Business Unit Business Development actively seeks opportunities to partner and collaborate with companies that have novel ideas for differentiated products with potential for meaningful impact to patients. We are focusing on our broad Hospital portfolio that includes anti-infectives, sterile injectables, surgical products, anesthesia and uniquely differentiated Hospital products.
We pride ourselves on being a creative, collaborative partner with a strong foundation in integrity, trust, and respect in all our partner relationships. We welcome all inquiries about potential opportunities and are committed to a timely response.